TFC Financial Management’s Akero Therapeutics AKRO Stock Holding History

TFC Financial Management’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2	Closed	-$95	–	966
2025 Q3	$95	Hold	2	–	–	﹤0.01%	900
2025 Q2	$107	Hold	2	–	–	﹤0.01%	873
2025 Q1	$81	Buy	+2	New	+$85	﹤0.01%	858

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TFC Financial Management's AKRO Position: Q4 2025 in Review

TFC Financial Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 2 shares — an estimated $95 sold.

TFC Financial Management first reported a position in AKRO in Q1 2025 and held it in 3 quarters. The position peaked at $107 in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

TFC Financial Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
TFC Financial Management sold 2 Akero Therapeutics shares in Q4 2025, an estimated $95.
TFC Financial Management first reported a position in Akero Therapeutics in Q1 2025 and held it in 3 quarters.
TFC Financial Management's Akero Therapeutics position peaked at $107 in Q2 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on TFC Financial Management's 13F filing for Q4 2025, filed 23 Jan 2026.